The Myeloma Minutes24 Apr 2025

005 Taking Part in Research: Clinical Trials for Myeloma Explained

Welcome to The Myeloma Minutes.

In this episode Jam & Sally explore the role, process, benefits, and realities of clinical trials in myeloma care—what they are, how they work, and what patients and carers need to know.

Clinical trials offer access to cutting-edge treatments not yet widely available.
Taking part is always your choice—fully informed, and never pressured.
You’re not a guinea pig—trials are strictly regulated to keep you safe.

This podcast is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for personalised medical guidance regarding your health concerns

ABOUT YOUR HOSTS

Dr. Jam Kothari

Dr Jam Kothari (@myeloma_medic) is an Oxford based blood cancer doctor, specialising in the treatment of multiple myeloma and associated conditions. He has been a consultant for a decade, and leads the provision of myeloma care for Oxford and neighbouring areas. He lectures regionally and nationally and leads clinical trials investigating the use of new treatments for myeloma. He is a strong believer in patient based, holistic care, delivered with warmth, clarity and integrity.

Dr. Sally Moore

Dr Sally Moore is a Bristol based consultant who specialises in treating patients living with multiple myeloma and other plasma cell disorders. She oversees the delivery of clinical research studies for myeloma patients and has academic interests in how to maximise quality of life for patients and improve outcomes in older, less fit patients. She frequently contributes to myeloma related educational events for fellow doctors and healthcare professionals at a local, regional and national level and is an active member of the UK Myeloma Research Alliance and an executive member of the UK Myeloma Society.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(40)

040 From the Conference Floor: The Latest Advances in Myeloma Care

This episode explores the latest breakthroughs from the world's leading myeloma conferences, explaining how new research and clinical trials could shape future treatment and improve patient care with ...

30 Juli 41min

039 DT-PACE Explained: When Myeloma Needs a Different Approach

This episode explains when DT-PACE chemotherapy is used in myeloma, how it works, what patients can expect during treatment, and why it remains an important bridge to newer therapies.📌Key Takeaways: ...

14 Juli 23min

038 A New Four-Drug Treatment for Myeloma: What Does DVRD Mean for Patients?

Experts discuss the approval of the new DVRD four-drug treatment for newly diagnosed myeloma patients who are not eligible for a stem cell transplant, exploring its benefits, risks and how treatment d...

25 Juni 35min

037 From Patient to Author: Jonathan Gluck’s Myeloma Story

Author Jonathan Gluck shares his deeply personal experience of living with myeloma, reflecting on diagnosis, uncertainty, treatment, resilience and what it means to build a life alongside cancer.📌Key...

11 Juni 48min

036 Infection and Myeloma - Staying Safe Without Stopping Life

This episode explores why people with myeloma are more vulnerable to infection, how treatments affect immunity, and the practical steps patients and carers can take to stay well.📌Key Takeaways:Myelom...

29 Maj 41min

035 Blood Clots and Myeloma - What Every Patient Should Know

This episode explains why people with myeloma are at higher risk of blood clots, how blood thinners help, and the warning signs patients and carers should never ignore. 📌Key Takeaways: Myeloma and s...

14 Maj 27min

034 Pain in Myeloma - Understanding It and Taking Back Control

This episode explores why pain happens in myeloma, how it affects daily life, and the many ways it can be managed - from painkillers to specialist support. 📌Key Takeaways: Myeloma pain is common - b...

1 Maj 38min

033 MRD Explained: How Much Myeloma Is Really Left

This episode explains minimal residual disease (MRD) - what it is, how it’s measured, and how it could shape more personalised myeloma treatment in the future. 📌Key Takeaways: Even when blood tests ...

9 Apr 29min